drugset / Trial / NCT00106847
A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety and effectiveness of scheduled and as needed treatment of psoriasis with infliximab. Infliximab (Remicade) targets specific proteins in the body's immune system to help control the development of inflammation to help reduce painful disease.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Infliximab | Monoclonal antibody | 3 mg/kg | — |
| Subject | Infliximab | Monoclonal antibody | 5 mg/kg | — |